A retrospective analysis of cross-reacting cetuximab IgE antibody and its association with severe infusion reactions

Severe infusion reactions (SIRs) at rates of 5% or less are known side effects of biological agents, including mAbs such as cetuximab. There are currently no prospectively validated risk factors to aid physicians in identifying patients who may be at risk of experiencing an SIR following administrat...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Med
Main Authors: Maier, Sabine, Chung, Christine H, Morse, Michael, Platts-Mills, Thomas, Townes, Leigh, Mukhopadhyay, Pralay, Bhagavatheeswaran, Prabhu, Racenberg, Jan, Trifan, Ovidiu C
Format: Artigo
Language:Inglês
Published: BlackWell Publishing Ltd 2015
Subjects:
Cancer Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4312116/
https://ncbi.nlm.nih.gov/pubmed/25296628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.333
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items